Athira Pharma (ATHA) Insider Trading & Ownership $0.33 +0.03 (+9.93%) Closing price 07/3/2025 03:44 PM EasternExtended Trading$0.33 0.00 (-0.30%) As of 07/3/2025 04:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Athira Pharma (NASDAQ:ATHA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage22.10%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$45.28K Get ATHA Insider Trade Alerts Want to know when executives and insiders are buying or selling Athira Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ATHA Insider Buying and Selling by Quarter Athira Pharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/1/2025Mark James LittonCEOSell25,123$0.29$7,285.67 7/1/2025Mark WorthingtonGeneral CounselSell8,526$0.29$2,472.54 7/1/2025Martin Javier SanInsiderSell10,842$0.29$3,144.18 7/1/2025Robert RenningerSVPSell2,897$0.29$840.13 1/2/2025Mark James LittonCEOSell25,107$0.56$14,059.92 1/2/2025Mark WorthingtonGeneral CounselSell8,510$0.56$4,765.60 1/2/2025Martin Javier SanInsiderSell10,826$0.56$6,062.56 1/2/2025Robert RenningerVPSell2,881$0.56$1,613.36 9/5/2024Andrew GengosCFOSell1,272$0.57$725.04 9/5/2024Mark James LittonCEOSell5,032$0.57$2,868.24 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 9/5/2024Rachel LeningtonCOOSell2,525$0.57$1,439.25 (Data available from 1/1/2013 forward) ATHA Insider Trading Activity - Frequently Asked Questions Who is on Athira Pharma's Insider Roster? The list of insiders at Athira Pharma includes Andrew Gengos, Glenna Mileson, Hans Moebius, James A Johnson, Kelly A Romano, Mark James Litton, Mark Worthington, Martin Javier San, Perceptive Advisors Llc, Rachel Lenington, and Robert Renninger. Learn more on insiders at ATHA. What percentage of Athira Pharma stock is owned by insiders? 22.10% of Athira Pharma stock is owned by insiders. Learn more on ATHA's insider holdings. Which Athira Pharma insiders have been buying company stock? The following insiders have purchased ATHA shares in the last 24 months: Kelly A Romano ($100,208.00), and Perceptive Advisors Llc ($463,476.04). How much insider buying is happening at Athira Pharma? Insiders have purchased a total of 238,488 ATHA shares in the last 24 months for a total of $563,684.04 bought. Which Athira Pharma insiders have been selling company stock? The following insiders have sold ATHA shares in the last 24 months: Andrew Gengos ($4,240.32), Mark James Litton ($38,240.03), Mark Worthington ($14,257.06), Martin Javier San ($9,206.74), Rachel Lenington ($1,439.25), and Robert Renninger ($2,453.49). How much insider selling is happening at Athira Pharma? Insiders have sold a total of 111,981 Athira Pharma shares in the last 24 months for a total of $69,836.89 sold. More Insider Trading Tools from MarketBeat Related Companies XCUR Insider Trading ADVM Insider Trading ALGS Insider Trading STTK Insider Trading MRSN Insider Trading NBRV Insider Trading MURA Insider Trading CELU Insider Trading LIAN Insider Trading ITRM Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling at NVIDIA Could Turn Into an Opportunity The Top Insider Sells From Q2: Buy, Sell, or Hold?3 Hot Trades for Insiders, But Are They Good Buys for Investors?Insiders Chase Income and Stability in American Tower—Here’s Why3 Tech Stocks With High and Rising Institutional Interest This page (NASDAQ:ATHA) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored140% Yields From Stocks Like Tesla? Here's How (July 4th Special)Imagine getting a 140% dividend from your investments. Even better? It works with big names like Tesla, ...Investors Alley | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Athira Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Athira Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ATHA Stock Alerts